TG Therapeutics | TGTX - Net Income



TG Therapeutics reported $28.19M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Alaunos Therapeutics USD -742000 385K Dec/2024
Amgen USD 1.43B 298M Jun/2025
Ardelyx USD -19080000 23.72M Jun/2025
Arrowhead Research USD -175241000 545.69M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Dynavax Technologies USD 18.72M 114.82M Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Novartis USD 4.02B 418M Jun/2025
PTC Therapeutics USD -64849000 931.41M Jun/2025
Regeneron Pharmaceuticals USD 1.39B 582.9M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
TG Therapeutics USD 28.19M 23.13M Jun/2025
Vertex Pharmaceuticals USD 1.03B 386.6M Jun/2025